Transcept Pharmaceuticals Inc. Enters Oversold Territory - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Transcept Pharmaceuticals Inc. 's ( TSPT ) share price has entered into oversold territory with a stochastic value of 3.3220. The Zacks Consensus Estimate on the company's loss for year ending December 2012 decreased by 4 cents over the past two months to a loss of 71 cents per share. Transcept Pharmaceuticals Inc. is a Zacks #2 Rank ("Buy") company.


TRANSCEPT PHARM (TSPT): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: TSPT

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by